Publications

Rameseder J, Krismer K, Dayma Y, Ehrenberger T, Hwang MK, Airoldi EM, Floyd SR, Yaffe MB. “A Multivariate Computational Method to Analyze High-Content RNAi Screening Data.” Journal of Biomolecular Screening, 2015, Sep., 20(8):985-97.

Rangachari D, Yamaguchi N, VanderLaan PA, Folch E, Mahadevan A, Floyd SR, Uhlmann EJ, Wong ET, Dahlberg SE, Huberman MS, Costa DB. “Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers.”  Lung Cancer, 2015, Apr., 88(1):108-11.

Dyer MA, Arvold ND, Chen YH, Pinnell NE, Mitin T, Lee EQ, Hodi FS, Ibrahim N, Weiss SE, Kelly PJ, Floyd SR, Mahadevan A, Alexander BM. “The role of whole brain radiation therapy in the management of melanoma brain metastases.” Radiation Oncology, 2014, Jun. 22, 9:143.

Mitin T, Chen YH, Catalano PJ, Floyd SR, Kapser EM, Mahadevan A. “The role of systemic disease status in treatment outcomes for patients with newly diagnosed brain oligometastases and treated with stereotactic radiosurgery alone.” Journal of Radiation Oncology,  Published Online 2013, Aug. 25.

Floyd SR, Pacold ME, Huang Q, Clarke SM, Lam FC, Cannell IG, Bryson BD, Rameseder J, Lee MJ, Blake EJ, Fydrych A, Ho R, Greenberger BA, Chen GC, Maffa A, Del Rosario AM, Root DE, Carpenter AE, Hahn WC, Sabatini DM, Chen CC, White FM, Bradner JE, Yaffe MB. “The bromodomain protein Brd4 insulates chromatin from DNA damage signaling.” Nature, 2013, Jun. 13, 498(7453):246-50.

Weingeist DM, Wood DK, Mutamba JT, Qiuying H, Rowland EA, Yaffe MB, Floyd SR, Engelward BP. “Single cell microarray enables high throughput evaluation of DNA double strand breaks and DNA repair inhibitors.” Cell Cycle, 2013, Mar. 15, 12(6):907-15.

Floyd SR, Kasper EM, Uhlmann EJ, Fonkem E, Wong ET. “Hypofractionated radiotherapy and stereotactic boost with concurrent and adjuvant temozolomide for glioblastoma in good performance status elderly patients – Early results of a Phase II trial.”  Frontiers in Oncology, 2012, Oct. 16, 2:122.

Fonkem E, Uhlmann EJ, Floyd SR, Mahadevan A, Kasper E, Eton O, Wong ET. “Melanoma brain metastasis: overview of current management and emerging targeted therapies.” Expert Review of Neurotherapeutics, 2012, Oct., 12(10):1207-15.

Wang CC, Floyd SR, Chang CH, Warnke PC, Chio CC, Kasper EM, Mahadevan A, Wong ET, Chen CC. “Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimen.” Journal of  Neurooncology, 2012, Feb., 106(3):601-10.

 Lu XQ, Mahadevan A, Mathiowitz G, Lin PJ, Thomas A, Kasper EM, Floyd SR, Holupka E, La Rosa S, Wang F, Stevenson MA. “Frameless angiogram-based stereotactic radiosurgery for treatment of arteriovenous malformations.” International Journal of Radiation Oncology, Biology, Physics, 2012, Sep. 1, 84(1):274-82.

Mahadevan A, Floyd S, Wong E, Chen C, Kasper E. “Clinical outcome after hypofractionated stereotactic radiotherapy (HSRT) for benign skull base tumors.” Comput Aided Surg. 2011, 16(3):112-20.

Mahadevan A, Floyd S, Wong E, Jeyapalan S, Groff M, Kasper E. “Stereotactic body radiotherapy reirradiation for recurrent epidural spinal metastases.” International Journal of Radiation Oncology, Biology, Physics, 2011, Dec. 1, 81(5):1500-5.

Floyd SR, Buchholz TA, Haffty BG, Strom EA, Goldberg S, Abi Raad RF, Niemierko A, Oswald MJ, Powell SN, Katz A, Taghian AG.  “Low local recurrence rate without post-mastectomy radiation in node-negative breast cancer patients with tumors 5cm and larger.” International Journal of Radiation Oncology, Biology, Physics, 2006, Oct. 1, 66(2):358-64.

Taghian AG, Assaad SI, Niemierko A, Floyd SR, Powell SN. “Is a reduction in the radiation lung volume and dose necessary with paclitaxel chemotherapy for node positive breast cancer?” International Journal of Radiation Oncology, Biology, Physics, 2005, Jun. 1, 62(2):386-91.

Schmierer K, Grosse P, De Camilli P, Solimena M, Floyd S, Zschenderlein R. “Paraneoplastic stiff-person syndrome: no tumor progression over 5 years.”  Neurology, 2002, Jan. 8, 58(1):148.

Farsad K, Ringstad N, Takei K, Floyd SR, Rose K, De Camilli P.  “Generation of high curvature membranes mediated by direct endophilin bilayer interactions.”  Journal of Cell Biology, 2001, Oct. 15, 155(2):193-200.

Floyd SR, Porro EB, Slepnev VI, Ochoa GC, Tsai LH, De Camilli P.  “Amphiphysin 1 binds the cyclin dependent kinase (cdk) 5 regulatory subunit p35 and is phosphorylated by cdk5 and cdc2.” Journal of Biological Chemistry, 2001, Mar. 16, 276(11):8104-10.

Ferracci F, Fassetta G, Butler MH, Floyd S, Solimena M, De Camilli P.  “A novel antineuronal antibody in a motor neuron syndrome associated with breast cancer.” Neurology, 1999, Sept. 11, 53(4):852-5.

Floyd S, Butler MH, Cremona O, David C, Freyberg Z, Zhang X, Solimena M, Tokunaga A, Ishizu H, Tsutsui K, De Camilli P. Expression of amphiphysin I, an autoantigen of paraneoplastic neurological syndromes, in breast cancer.  Molecular Medicine, 1998, Jan., 4(1):29-39.